Catalyst Wire Dossier Catalyst Wire Dossier

Ritonavir-boosted atazanavir

atazanavir/ritonavir · Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ritonavir-boosted atazanavir, covering 2015-03-30 to 2023-12-19. Get the full timeline:

Most recent: Clinical Trial Update: Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone [Phase 3]

See pricing